Asosiy kontentga oʻtish
Maqola

Posters Presentations: P3-501–P2-720

Anjumanara OmarL Lisowicz Regional Hospital No2, Pediatrics, Rzeszow, PolandSerap TuranMarmara University, Pediatric Endocrinology, Istanbul, TurkeyAbdullah BereketAristotle University of Thessaloniki, 3rd Pediatric Dept, Thessaloniki, GreeceBarbara PredieriUniversity of Lige, Pediatrics, Lige, Belgium;Lorenzo IughettiUniversity of Modena & Reggio Emilia, Pediatrics, Modena, Italy;Rosario RossiUniversity of Edinburgh, Management School and Economics, Edinburgh, United KingdomAnna Maria NuzzoImmunology, Immunogenetic, Tashkent, UzbekistanElena CioniMathematical Institute, Lige, BelgiumF. BalliGeneral Hospital, Pediatrics, Le Mans, France;Maria Grazia ModenaUniversity of Edinburgh, Management School and Economics, Edinburgh, United KingdomSimone Guimarães Teixeira SoutoEndocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan;N BencherifaUniversity of Edinburgh, Management School and Economics, Edinburgh, United KingdomF GatelaisUniversity Hospital, Pediatrics, Angers, FranceChristel VoinotUniversity of Edinburgh, Management School and Economics, Edinburgh, United KingdomS RouleauMathematical Institute, Lige, BelgiumJ.M. LimalUniversity of Edinburgh, Management School and Economics, Edinburgh, United KingdomR. CoutantImmunology, Immunogenetic, Tashkent, UzbekistanFiliz ÇizmecioğluEndocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan;Patricia M. CroftonUniversity of Edinburgh, Department of Biochemistry and Child Life and Health, Edinburgh, United Kingdom;Ercan BalabanUniversity of Edinburgh, Management School and Economics, Edinburgh, United KingdomKathryn NoyesUniversity of Modena & Reggio Emilia, Pediatrics, Modena, Italy;Louise BathUniversity of Modena & Reggio Emilia, Pediatrics, Modena, Italy;J KelnarEndocrinology, Pediatric Endocrinology, Tashkent, Uzbekistan;M MassinUniversity of Modena & Reggio Emilia, Pediatrics, Modena, Italy;F JastrowiczUniversity of Edinburgh, Department of Biochemistry and Child Life and Health, Edinburgh, United Kingdom;M C LebrethonUniversity of Lige, Pediatrics, Lige, Belgium;Laetitia ComtéUniversity of Edinburgh, Management School and Economics, Edinburgh, United KingdomA. BourguignontUniversity of Modena & Reggio Emilia, Pediatrics, Modena, Italy;Jessica MontesantiUniversity of Modena & Reggio Emilia, Pediatrics, Modena, Italy;D RocourUniversity of Lige, Pediatrics, Lige, Belgium;Paul GérardUniversity of Edinburgh, Management School and Economics, Edinburgh, United KingdomJean-Pierre BourguignonUniversity of Lige, Pediatrics, Lige, Belgium;M OlpinskiL Lisowicz Regional Hospital No2, Pediatrics, Rzeszow, PolandArtur MazurL Lisowicz Regional Hospital No2, Pediatrics, Rzeszow, PolandMaria PapagianniL Lisowicz Regional Hospital No2, Pediatrics, Rzeszow, PolandMaria S. PapadopoulouL Lisowicz Regional Hospital No2, Pediatrics, Rzeszow, PolandI HatziioanidisMarmara University, Pediatric Endocrinology, Istanbul, TurkeyT Papastavrou- MavroudiL Lisowicz Regional Hospital No2, Pediatrics, Rzeszow, PolandL DoumaAristotle University of Thessaloniki, 3rd Pediatric Dept, Thessaloniki, GreeceSayyora AkhmedovaUniversity of Edinburgh, Department of Biochemistry and Child Life and Health, Edinburgh, United Kingdom;Gulnara RakhimovaUniversity of Lige, Pediatrics, Lige, Belgium;Д. А. РахимоваUniversity Hospital, Pediatrics, Angers, France
ABI

Annotatsiya

In diabetic ketoacidosis (DKA), hydroxy butyrate (OHB) is the major ketone body accumulated in blood. During treatment of DKA, OHB is converted to acetoacetate and acetone which are excreted in the urine. Venous OHB level is the preferred test for monitoring metabolic status in DKA but cost and unavailability limits its use. Ketone monitoring is usually done semiquantitatively by measuring urinary ketones. However, persistence of ketones in the urine, despite metabolic improvement is seen due to the above mentioned limitations. We aimed to compare the sensitivity of capillary OHB by electrochemical method with urinary ketone measurement during treatment of DKA Patients with DKA admitted to the hospital were followed with simultaneous measurements of fingerstick capillary OHBmeasured by electrochemical method (Medisense Optium, Abbott), and urinary ketone by dipstick method. Blood gases were measured in 2-4 hrs intervals. The relationship between simultaneous measurements of urine ketone, blood ketone, blood pH and HCO3 were investigated. 14 patients with DKA (7 M, 7 F, Age: 9.2 4.2 yr) were included with 50 simultaneous measurements of capillary and urinary ketone. Blood gases were assessed 2-4 hourly. No correlation was detected between urine ketone and blood PH (p=0.06) and HCO3 (p=0.79) while a significant negative correlation was found between capillary blood ketone and blood pH (r:-0.41, p <0.05) and HCO3 (r:-0.35, p<0.05). Capillary OHB and urine ketones did not correlate at the beginning and 3.3 1.4 hrs after treatment, but did correlate in the third samples taken 7.8 2.0 hrs after treatment (p<0.05). We conclude that capillary blood OHB level shows good correlation with the degree of acidosis (pH and HCO3) during DKA management. Capillary OHB is more sensitive than urinary ketone measurement in reflecting the patient's metabolic status and improvement during treatment.

Hali tarjima qilinmagan

Mavzular

Identifikatorlar

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba